Header cover image

Australian Pharmaceuticals & Biotech Top Growth Stocks

Results

6

2 new
According to our Simply Wall St analysis these are the best growth companies.. We look for companies with high forecasted growth and healthy balance sheets that can deliver sustained growth over the long term.

6 companies

Immutep

Market Cap: AU$344.9m

A biotechnology company, engages in developing novel Lymphocyte Activation Gene-3 related immunotherapies for cancer and autoimmune diseases in Australia.

IMM

AU$0.23

7D

0%

1Y

-39.7%

EZZ Life Science Holdings

Market Cap: AU$103.8m

Engages in formulation, production, marketing, and sale of the health and wellbeing products in Australia, New Zealand, Mainland China, and South-East Asia.

EZZ

AU$2.20

7D

-6.4%

1Y

-22.8%

Mesoblast

Market Cap: AU$2.7b

Engages in the development of regenerative medicine products in Australia, the United States, Singapore, and Switzerland.

MSB

AU$2.12

7D

-2.8%

1Y

124.3%

Alterity Therapeutics

Market Cap: AU$119.7m

Engages in the research and development of therapeutic drugs to treat Alzheimer’s disease, Huntington disease, Parkinson’s disease, and other neurological disorders in Australia.

New

ATH

AU$0.013

7D

-7.1%

1Y

333.3%

Clinuvel Pharmaceuticals

Market Cap: AU$565.4m

A biopharmaceutical company, focuses on developing and commercializing treatments for patients with genetic, metabolic, systemic, and life-threatening disorders in Australia, Europe, the United States, Switzerland, and internationally.

CUV

AU$11.28

7D

5.9%

1Y

-23.4%

Genetic Signatures

Market Cap: AU$63.6m

Operates as a molecular diagnostic company in Australia, the Asia Pacific, Europe, the Middle East, Asia, and the Americas.

New

GSS

AU$0.28

7D

3.7%

1Y

-60.0%